During the Trading Day
3.00 -0.03 / -0.99%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.10 +0.10 / +3.33%
Volume: 27.2K
Health Technology

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company currently in developmental stage that seeks to acquire, develop and commercialize, on its own or with commercial partners, a diverse portfolio of cancer therapies. The company also has a portfolio of small molecule drug candidates, which are no longer a strategic focus of its development activities for which the company is seeking partners to pursue further development and commercialization. It is currently focused on two clinical stage product candidates: Ad-RTS-IL-12 + veledimex and DC-RTS-IL-12 + veledimex. Ziopharm Oncology was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
Parris Building
Boston Massachusetts 02129
P:(617) 259-1970
Investor Relations:



Individual stakeholders32.82%
Mutual fund holders15.04%
Other institutional14.99%

Top Executives

Jonathan J. LewisChief Executive Officer & Director
Kevin G. LafondChief Financial Officer, Treasurer, CAO & VP
J. Kris PiperVice President-Clinical Regulatory & Quality
Francois LebelSVP-Clinical Development & Medical Operations
Caesar J. BelbelSecretary, Chief Legal Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.